Valvular Heart Disease
Conditions
Interventions
Sponsors
NO
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: a) Patients with significant MR or AS (=mild); b) Patients with organic MR or AS; c) Patients able to undergo a comprehensive echocardiographic evaluation; d) The patient or the guardian gives written informed consent before participating the study; e) The patient is willing to give full information on his/her medical history, including the drugs.
Exclusion criteria
Exclusion criteria: a) Patient with functional (for example, ischemic MR) MR; b) Patient with concomitant valvular heart disease other than MR or AS; c) Patient with other concomitant congenital heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite endpoint of admission for heart failure, worsening of functional capacity with NYHA functional classification and death.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Functioncal capacity with NYHA functional classification;(Sudden) Cardiac death;Hospitalization for worsening heart failure;Stroke;Significant arrhythmia that needs admission.;Surgery for worsening valvular heart disease;Echocardiographic parameters, such as LV dimension, ejection fraction, pulmonary artery systolic pressure; | — |
Countries
China
Contacts
Public ContactProf.Cheuk-Man YU
Outcome results
None listed